Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10017933
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10017933
Fusion event
HBV-C3 integration
Validated
No
Detection method
TS
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
26867494
Virus Sequence
Virus name
HBV
Subtype
C
Reference genome
DQ089769.1
Region type
pre-S1/pre-S2/S;Polymerase;
Start
371
Integrated sequence
AATTTTCTAGGGGGAGCACCCACGTGTCCTGGCCAAAATTTGCAGTCCCCAACCTCCAATCACTCACCAACCTCTTGTCCTCCAATTTGTCCTGGTTATC| |GCTGGATGTGTCTGCGGCGTTTTATCATCTTCCTCTTCATCCTGCTGCTATGCCTCATCTTCTTGTTGGTTCTTCTGGACTACCAAGGTATGTTGCCCGT
Host Sequence
Chromosome
chr19
Cytoband
p13.3
Reference genome
GRCh37/hg19
Start
6719361/6719350 (Hg38)
End
6719361/6719350 (Hg38)
Location type
Exonic
Fragile sites / regions
FRA19B
Target gene
C3
miRNAs that regulate target gene
hsa-mir-98-5p
;
hsa-mir-26b-5p
;
hsa-mir-6516-5p
;
hsa-mir-550b-2-5p
;
hsa-mir-455-3p
;
hsa-mir-7847-3p
;
hsa-mir-1227-3p
;
hsa-mir-6880-5p
;
hsa-mir-6799-5p
;
hsa-mir-6851-5p
;
hsa-mir-4252
;
hsa-mir-3689d
;
hsa-mir-6499-3p
;
hsa-mir-6086
;
hsa-mir-377-5p
;
hsa-mir-6134
;
hsa-mir-4537
;
hsa-mir-5186
;
hsa-mir-1247-3p
;
hsa-mir-7151-3p
;
hsa-mir-5095
;
hsa-mir-6889-3p
;
hsa-mir-6504-3p
;
hsa-mir-4438
;
hsa-mir-5001-3p
;
hsa-mir-6720-5p
;
hsa-mir-6512-3p
;
hsa-mir-6729-5p
;
hsa-mir-4649-5p
;
hsa-mir-1273a
;
hsa-mir-661
;
hsa-mir-4486
;
hsa-mir-4522
;
hsa-mir-766-3p
;
hsa-mir-6849-3p
;
hsa-mir-939-3p
;
hsa-mir-4432
;
hsa-mir-589-3p
;
hsa-mir-5698
;
hsa-mir-6722-5p
;
hsa-mir-4638-5p
;
hsa-mir-1307-3p
;
hsa-mir-6741-3p
;
hsa-mir-1306-5p
;
hsa-mir-4284
;
hsa-mir-122-5p
;
hsa-mir-504-3p
;
hsa-mir-3135b
;
hsa-mir-4772-3p
;
hsa-mir-1304-3p
;
hsa-mir-4532
;
hsa-mir-6890-3p
;
hsa-mir-665
;
hsa-mir-887-5p
;
hsa-mir-6780a-5p
;
hsa-mir-6779-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-6788-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-1273e
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-7160-5p
;
hsa-mir-4722-5p
;
hsa-mir-6884-5p
;
hsa-mir-485-5p
;
hsa-mir-1827
;
hsa-mir-219b-3p
;
hsa-mir-4649-3p
;
hsa-mir-4768-3p
;
hsa-mir-6787-3p
;
hsa-mir-5690
;
hsa-mir-4478
;
hsa-mir-4419b
;
hsa-mir-3929
;
hsa-mir-940
;
hsa-mir-6893-5p
;
hsa-mir-6808-5p
;
hsa-mir-890
;
hsa-mir-302f
;
hsa-mir-216b-5p
;
hsa-mir-216a-5p
;
hsa-mir-7703
;
hsa-mir-4793-3p
;
hsa-mir-1273g-3p
;
hsa-mir-127-5p
;
hsa-mir-1297
;
hsa-mir-25-5p
;
hsa-mir-26a-5p
;
hsa-mir-3192-5p
;
hsa-mir-3199
;
hsa-mir-320e
;
hsa-mir-365a-5p
;
hsa-mir-365b-5p
;
hsa-mir-3928-5p
;
hsa-mir-4459
;
hsa-mir-4465
;
hsa-mir-4635
;
hsa-mir-513c-5p
;
hsa-mir-514b-5p
;
hsa-mir-552-3p
;
hsa-mir-562
;
hsa-mir-5697
;
hsa-mir-6087
;
hsa-mir-658
;
hsa-mir-6806-3p
;
hsa-mir-6819-3p
;
hsa-mir-6877-3p
;
hsa-mir-7843-3p
;
hsa-mir-8052
Nearest miRNA
hsa-mir-1227/Upstream/302839; hsa-let-7e/Downstream/17362;
Nearest TSS
ENST00000633603/Upstream/4999;
ENST00000596543/Downstream/1300;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/11794
,
chr19-CpG: 59/Downstream/17878
Upstream sequence
agagtggactgctgggtcccagggagaaggagctgtgggccccagttcctgggtcctgaggTCTGACTTTCTTGCTTTTCCCATCTGCAGCGGCTGAGGG
Downstream sequence
CCATGGTCTCCTCGCTCTCCAGCCGCAAGATGTTGGGGGTGATGATAGAGTACCTGTCGGAGTGGGGCACGGGAGTGGGCTTGTCATTCCACGGATGTGA
Reference
Chiu, Y. T., et al. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma. J Hepatol ,2016,64(6): 1256-1264.
Sample Information
×
Sample name
74T
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate